ProBioGen AG
Ulrike Rennefahrt, Ph.D. has extensive experience in project management in the field of biomarker discovery and development. Currently working as a CMC Project Manager at ProBioGen AG, they have previously held senior positions at Metanomics Health and metanomics GmbH - BASF company. With a Ph.D. in Tumor Biology from The Julius Maximilians University of Würzburg, they have a strong background in research and data analysis in various indication fields.
This person is not in the org chart
ProBioGen AG
ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines. Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon. With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.